| 2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide | IC50 | 926.0 [1] |
| 1-[5-[(4,5-Diphenyl-1H-imidazol-2-yl)sulfanyl]pentyl]-3,5-dimethylpyrazole | IC50 | 53.0 [1] |
| (5E,8E,11E,14E,17E,20E)-N-[2,6-Di(propan-2-yl)phenyl]docosa-5,8,11,14,17,20-hexaenamide | IC50 | 36.0 [1] |
| N-[2,6-Di(propan-2-yl)phenyl]tetradecanethioamide | IC50 | 130.0 [1] |
| Avasimibe | IC50 | 25.0 [1], 479.0 [2], 1500.0 [3], 4100.0 [4], 23500.0 [5] |
| 3-(2,4-Difluorophenyl)-1-[4-(2,2-dimethylpropyl)benzyl]-1-heptylurea | IC50 | 140.0 [1], 740.0 [2], 810.0 [3], 1090.0 [4], 6060.0 [5] |
| Oleanilide | IC50 | 140.0 [1], 170.0 [2] |
| (5,9-Diacetyloxy-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-8,12,17-trien-6-yl)methyl acetate | IC50 | 640.0 [1], 80000.0 [2], 1000000.0 [3] |
| 1-(5-((4,5-Diphenyl-1H-imidazol-2-yl)sulfinyl)pentyl)-3,5-dimethyl-1H-pyrazole | IC50 | 108.0 [1], 164.0 [2], 240.0 [3], 300.0 [4] |
| Pactimibe | IC50 | 300.0 [1], 1800.0 [2], 4900.0 [3] |
| Nonanoic acid biphenyl-2-ylamide | IC50 | 64600.0 [1], 65000.0 [2] |
| Octanoic acid biphenyl-2-ylamide | IC50 | 60900.0 [1], 61000.0 [2] |
| Oleic acid | IC50 | 1000000.0 [1] |
| Linoleic acid | IC50 | 1000000.0 [1] |
| Oleamide | IC50 | 63000.0 [1], 85000.0 [2] |
| Beauveriolide III | IC50 | 410.0 [1], 900.0 [2] |
| 1-(3,4-Dimethoxyphenyl)-2-[4-[(2S,3R,4R,5S)-5-[4-[1-(3,4-dimethoxyphenyl)-1-hydroxypropan-2-yl]oxy-3-methoxyphenyl]-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy]propan-1-ol | IC50 | 8000.0 [1], 39000.0 [2] |
| Eflucimibe | IC50 | 39.0 [1] |
| Linoleamide | IC50 | 45000.0 [1], 53000.0 [2] |
| CID 9892288 | IC50 | 450.0 [1] |
| Isovalerylshikonin | IC50 | 600.0 [1], 13800.0 [2] |
| 1-(1,3-Benzodioxol-5-yl)-2-[4-[(2S,3R,4R,5S)-5-[4-[1-(3,4-dimethoxyphenyl)-1-hydroxypropan-2-yl]oxy-3-methoxyphenyl]-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy]propan-1-ol | IC50 | 82000.0 [1] |
| 4-[1-[5-[6-(Trifluoromethyl)-1H-benzimidazol-2-yl]pyridin-2-yl]piperidin-4-yl]oxycyclohexane-1-carboxylic acid | IC50 | 10000.0 [1] |
| [(1S,2S,5S,6R,7R,9S,10S,18R)-5-Acetyloxy-6-(acetyloxymethyl)-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-9-yl] 4-cyanobenzoate | IC50 | 4160.0 [1] |
| Beauveriolide I | IC50 | 600.0 [1], 780.0 [2] |
| 2-[4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide;hydrochloride | IC50 | 26.0 [1], 450.0 [2] |
| 1-{4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-[1,3]dioxan-5-yl]-butyl}-3,5-dimethyl-1H-pyrazole | IC50 | 75.0 [1], 500.0 [2] |
| 4-[1-[5-(6-Fluoro-1H-benzimidazol-2-yl)pyridin-2-yl]piperidin-4-yl]oxycyclohexane-1-carboxylic acid | IC50 | 10000.0 [1] |
| 4-[1-[5-(6-Chloro-1H-benzimidazol-2-yl)pyridin-2-yl]piperidin-4-yl]oxycyclohexane-1-carboxylic acid | IC50 | 10000.0 [1] |
| 4-[3-Fluoro-4-[[5-(2,4,5-trifluoroanilino)-1,3,4-oxadiazole-2-carbonyl]amino]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 310.0 [1], 6500.0 [2] |
| 4-[4-[[5-(2,4,5-Trifluoroanilino)-1,3,4-oxadiazole-2-carbonyl]amino]phenoxy]cyclohexane-1-carboxylic acid | IC50 | 450.0 [1], 1300.0 [2] |
| Progesterone | IC50 | 17000.0 [1] |
| Diethyl pyrocarbonate | IC50 | 44000.0 [1] |
| Shikonin | IC50 | 70400.0 [1] |
| Unii-ST04094S3X | IC50 | 128900.0 [1] |
| Kurarinone | IC50 | 10900.0 [1] |
| 1,4-Bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone | IC50 | 26000.0 [1] |
| Territrem B | IC50 | 50000.0 [1] |
| Manassantin B | IC50 | 82000.0 [1] |
| beta-Hydroxyisovalerylshikonin | IC50 | 186900.0 [1] |
| [(1S,2S)-2-[[2,2-Dimethylpropyl(nonyl)carbamoyl]amino]cyclohexyl] 3-[[(4R)-2,2,5,5-tetramethyl-1,3-dioxane-4-carbonyl]amino]propanoate | IC50 | 32.0 [1] |
| CID 42636350 | IC50 | 34000.0 [1] |
| Pipercide | IC50 | 3700.0 [1] |
| DGAT-1 inhibitor | IC50 | 12000.0 [1] |
| Arisugacin A | IC50 | 50000.0 [1] |
| Macluraxanthone B | IC50 | 96000.0 [1] |
| Cudraxanthone L | IC50 | 68000.0 [1] |
| Cudraflavanone A | IC50 | 82400.0 [1] |
| 2-[4-[4-[[5-(3,4-Difluoroanilino)-1,3,4-oxadiazole-2-carbonyl]amino]phenyl]cyclohexyl]acetic acid | IC50 | 80.0 [1] |
| Cudraxanthone D | IC50 | 57600.0 [1] |
| 2-Methylthio-1,4-naphthoquinone | IC50 | 2820.0 [1] |
| Unii-G3MY6fge1J | IC50 | 10000.0 [1] |
| Cudraxanthone M | IC50 | 56800.0 [1] |
| DGAT-1 inhibitor 2 | IC50 | 5200.0 [1] |
| [(1S,2S,5S,6R,7R,9S,10S,18R)-9-Acetyloxy-6-(acetyloxymethyl)-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-5-yl] propanoate | IC50 | 27300.0 [1] |
| Butylshikonin | IC50 | 77600.0 [1] |
| 5,8,10-Trihydroxy-3,3-dimethyl-11-(2-methylbut-3-en-2-yl)pyrano[2,3-c]xanthen-7-one | IC50 | 40000.0 [1] |
| (3R,4R)-3-Ethyl-1-(4-methoxyphenyl)-4-phenyl-3-(3-phenylpropyl)azetidin-2-one | IC50 | 10000.0 [1] |
| Isocudraniaxanthone B | IC50 | 148000.0 [1] |
| Diethyl 2-morpholin-4-yl-4-phenyl-7-propylpyrrolo[2,1-f][1,2,4]triazine-5,6-dicarboxylate | IC50 | 500.0 [1] |
| Propionylshikonin | IC50 | 22400.0 [1] |
| 2-Ethylsulfanylnaphthalene-1,4-dione | IC50 | 7510.0 [1] |
| Cudraxanthone C | IC50 | 20000.0 [1] |
| (3S,4R)-3-Ethyl-4-phenyl-3-(3-phenylpropyl)-1-(2,4,6-trimethoxyphenyl)azetidin-2-one | IC50 | 1700.0 [1] |
| (3S,4R)-1-(4-Methoxy-phenyl)-3,4-diphenyl-3-phenylacetyl-azetidin-2-one | IC50 | 7500.0 [1] |
| (3S,4R)-1-(4-Methoxy-phenyl)-3,4-diphenyl-3-(3-phenyl-propyl)-azetidin-2-one | IC50 | 6000.0 [1] |
| [(1R)-1-(5,8-Dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] pentanoate | IC50 | 94800.0 [1] |
| 2-[(R)-1-(Benzoyloxy)-4-methyl-3-pentenyl]-5,8-dihydroxy-1,4-naphthoquinone | IC50 | 53700.0 [1] |
| [(1S,2S,5S,6R,7R,9S,10S,18R)-5-Acetyloxy-6-(acetyloxymethyl)-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-9-yl] benzoate | IC50 | 680.0 [1] |
| (3R,6S,9S,13S)-9-Benzhydryl-3-[(2S)-butan-2-yl]-13-[(2S)-hexan-2-yl]-6-methyl-1-oxa-4,7,10-triazacyclotridecane-2,5,8,11-tetrone | IC50 | 40.0 [1] |
| (5As,7S)-7-[1-(6-imino-7H-purin-3-yl)propan-2-yl]-3-methyl-6,7,8,9-tetrahydro-5aH-pyrano[4,3-b]chromen-1-one | IC50 | 1200.0 [1] |
| SMP-797 hydrochloride monohydrate | IC50 | 31.0 [1] |
| 4-[4-[4-[[2-Phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carbonyl]amino]phenyl]piperidine-1-carbonyl]cyclohexane-1-carboxylic acid | IC50 | 68400.0 [1] |
| (3R,4S)-1-(4-Methoxyphenyl)-4-phenyl-3-(3-phenylpropyl)azetidin-2-one | IC50 | 10000.0 [1] |
| (2S)-5,7-Dihydroxy-2-(7-hydroxy-2,2-dimethylchromen-6-yl)-8-(3-hydroxy-3-methylbutyl)-2,3-dihydrochromen-4-one | IC50 | 59200.0 [1] |
| (3R,6R,9S,13S)-9-Benzhydryl-3-[(2S)-butan-2-yl]-13-[(2S)-hexan-2-yl]-6-methyl-1-oxa-4,7,10-triazacyclotridecane-2,5,8,11-tetrone | IC50 | 20.0 [1] |
| 1-(2,6-Diisopropylphenyl)-3-((4-(3-methoxyphenyl)-1-phenylpiperidin-4-yl)methyl)urea | IC50 | 35.0 [1] |
| 6-[[7-(Dimethylamino)-1,3-benzoxazol-2-yl]sulfanyl]-N-[2,6-di(propan-2-yl)phenyl]hexanamide | IC50 | 820.0 [1] |
| 6-[[7-[(Dimethylamino)methyl]-1,3-benzoxazol-2-yl]sulfanyl]-N-[2,6-di(propan-2-yl)phenyl]hexanamide | IC50 | 5600.0 [1] |
| ACAT-IN-1 cis isomer | IC50 | 40.0 [1] |
| 9-(1,3-Benzoxazol-2-ylsulfanyl)-N-[2,6-di(propan-2-yl)phenyl]nonanamide | IC50 | 7.0 [1] |
| N-[2-(4-Amino-phenyl)-1-phenyl-ethyl]-2,2-diphenyl-acetamide | IC50 | 900.0 [1] |
| N-(4,6-Dimethyl-1-octylindolin-7-yl)-2,2-dimethylpropanamide | IC50 | 640.0 [1] |
| [(1R)-1-(5,8-Dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] pent-4-enoate | IC50 | 30700.0 [1] |
| [(1S,2S,3R,11S,12S,14R,15R,18R,20S)-3-Hydroxy-1,11,15-trimethyl-5-oxo-18-phenyl-7-pyridin-3-yl-6,10,17,19-tetraoxapentacyclo[12.8.0.02,11.04,9.015,20]docosa-4(9),7-dien-12-yl] pentanoate | IC50 | 4000.0 [1] |
| N-Octyl-5,6-diphenylpyridazine-3-amine | IC50 | 3200.0 [1] |
| 1-{5-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-[1,3]dioxan-5-yl]-pentyl}-3,5-dimethyl-1H-pyrazole | IC50 | 60.0 [1] |
| 4-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]thiomorpholine | IC50 | 70.0 [1] |
| 2-[5-Methyl-5-(4-phenylmethoxybutyl)-1,3-dioxan-2-yl]-4,5-diphenyl-1H-imidazole | IC50 | 300.0 [1] |
| 1-Benzyl-4-[4-[2-(4,5-diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]piperazine | IC50 | 90.0 [1] |
| [(1S,2S,3R,11S,12S,14R,15R,18R,20S)-3-Hydroxy-1,11,15-trimethyl-18-(2-methylphenyl)-5-oxo-7-pyridin-3-yl-6,10,17,19-tetraoxapentacyclo[12.8.0.02,11.04,9.015,20]docosa-4(9),7-dien-12-yl] pentanoate | IC50 | 3200.0 [1] |
| 1-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]-4-phenylpiperazine | IC50 | 70.0 [1] |
| 2-[4-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]piperazin-1-yl]pyrimidine | IC50 | 75.0 [1] |
| [(1S,2S,5S,6R,7R,9S,10S,18R)-9-Acetyloxy-6-(acetyloxymethyl)-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-5-yl] 2-methylpropanoate | IC50 | 13600.0 [1] |
| 2-(5,5-Diethyl-[1,3]dioxan-2-yl)-4,5-diphenyl-1H-imidazole | IC50 | 1300.0 [1] |
| 1-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]indazole | IC50 | 130.0 [1] |
| [(1S,2S,5S,6R,7R,9S,10S,18R)-5,9-Diacetyloxy-18-hydroxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-6-yl]methyl 2-methylpropanoate | IC50 | 28000.0 [1] |
| N-Benzyl-4-[2-(4,5-diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]-N-methylbutan-1-amine | IC50 | 220.0 [1] |
| 2-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]-3,4-dihydro-1H-isoquinoline | IC50 | 60.0 [1] |
| 1-[4-[2-(4,5-Diphenyl-1H-imidazol-2-yl)-5-methyl-1,3-dioxan-5-yl]butyl]-4-(4-methoxyphenyl)piperazine | IC50 | 10.0 [1] |